Lawmakers Demand Answers from Novo Nordisk on Huge Ozempic Price Markups Compared to Production Costs

Study found it costs less than $5 to make a month's supply of popular diabetes drug Ozempic, but list price is over $900
Lawmakers and advocates calling on drugmaker Novo Nordisk to lower Ozempic's price in light of the findings
Sen. Bernie Sanders plans to meet with Novo Nordisk's CEO and is considering hearings on Ozempic's pricing
Rep. Dina Titus also called for Novo Nordisk to reduce Ozempic's cost, citing huge price difference between U.S. and Canada
Advocacy group Patients for Affordable Drugs highlighted huge markup from production cost to list price for Ozempic